HCC-associated lncRNA (HCC associated long non-coding RNA [HANR]; RPL13AP20)[15] has been shown to drive the enhanced proliferation, invasion, and epithelial-mesenchymal transition (EMT) of certain cancer cells.[16,17] Whether HANR exhibits any clinical relevance in patients with CRC, however, is unclear. This evidence concerns the gene RPL13AP20 and cancer.